Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 3.29% is 51% below its 5-year average of 6.73%, near the low end of its 5-year range (2.24%–16.00%).
As of the fiscal period ended Sunday, July 5, 2026. 0.06% above its 12-month average of 3.28%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-07-05): 3.29%.
RETURN ON EQUITY (ROE)
3.29%
RETURN ON EQUITY (ROE) AVG TTM
3.28%
RETURN ON EQUITY (ROE) AVG 3Y
4.42%
RETURN ON EQUITY (ROE) AVG 5Y
6.73%
RETURN ON EQUITY (ROE) AVG 10Y
7.81%
RETURN ON EQUITY (ROE) AVG 15Y
6.94%
RETURN ON EQUITY (ROE) AVG 20Y
7.10%
CURRENT VS TTM AVG
+0.06%
CURRENT VS 3Y AVG
-25.68%
CURRENT VS 5Y AVG
-51.20%
CURRENT VS 10Y AVG
-57.90%
CURRENT VS 15Y AVG
-52.62%
CURRENT VS 20Y AVG
-53.69%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-74.74%
vs the sector median at left
Revvity, Inc.
Market Cap
$16.31B
Return on Equity (ROE)
3.29%
TTM Avg
3.28%
3Y Avg
4.42%
5Y Avg
6.73%
Market Cap
$15.77B
Return on Equity (ROE)
29.88%
TTM Avg
23.51%
3Y Avg
17.50%
5Y Avg
13.68%
Market Cap
$17.27B
Return on Equity (ROE)
113.29%
TTM Avg
73.63%
3Y Avg
65.34%
5Y Avg
49.74%
Market Cap
$14.40B
Return on Equity (ROE)
46.68%
TTM Avg
29.72%
3Y Avg
22.87%
5Y Avg
17.28%
Market Cap
$18.98B
Return on Equity (ROE)
6.39%
TTM Avg
6.40%
3Y Avg
5.73%
5Y Avg
4.16%
Market Cap
$13.20B
Return on Equity (ROE)
-8.40%
TTM Avg
-2.13%
3Y Avg
6.32%
5Y Avg
9.65%
Market Cap
$19.55B
Return on Equity (ROE)
-2.88%
TTM Avg
-13.64%
3Y Avg
-4.29%
5Y Avg
-4.38%
Market Cap
$12.55B
Return on Equity (ROE)
10.49%
TTM Avg
6.83%
3Y Avg
5.29%
5Y Avg
3.21%
Market Cap
$12.49B
Return on Equity (ROE)
-57.18%
TTM Avg
-651.33%
3Y Avg
-315.37%
5Y Avg
-198.08%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revvity, Inc. (RVTY) | $16.31B | 3.29% | 3.28% | 4.42% | 6.73% |
| Solventum Corporation (SOLV)vs › | $15.77B | 29.88% | 23.51% | 17.50% | 13.68% |
| Medpace Holdings, Inc. (MEDP)vs › | $17.27B | 113.29% | 73.63% | 65.34% | 49.74% |
| Exelixis, Inc. (EXEL)vs › | $14.40B | 46.68% | 29.72% | 22.87% | 17.28% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.98B | 6.39% | 6.40% | 5.73% | 4.16% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.20B | -8.40% | -2.13% | 6.32% | 9.65% |
| Viatris Inc. (VTRS)vs › | $19.55B | -2.88% | -13.64% | -4.29% | -4.38% |
| Penumbra, Inc. (PEN)vs › | $12.55B | 10.49% | 6.83% | 5.29% | 3.21% |
| Tempus AI, Inc. (TEM)vs › | $12.49B | -57.18% | -651.33% | -315.37% | -198.08% |
| DaVita Inc. (DVA)vs › | $12.26B | N/A | 329.18% | 200.63% | 164.66% |
ROE
3.3%
ROA
2.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-07-05 | 3.29% |
| 2026-04-05 | 3.35% |
| 2025-12-28 | 3.34% |
| 2025-09-28 | 3.15% |
| 2024-12-29 | 3.86% |
| 2024-09-29 | 3.83% |
| 2024-06-30 | 2.78% |
| 2024-03-31 | 2.24% |
| 2023-12-31 | 9.11% |
| 2023-09-30 | 9.25% |
| 2022-10-02 | 8.72% |
| 2022-06-30 | 9.12% |
| 2022-03-31 | 10.03% |
| 2021-12-31 | 12.93% |
| 2021-09-30 | 16.00% |
| 2021-06-30 | 27.89% |
| 2021-03-31 | 26.83% |
| 2020-12-31 | 19.49% |
| 2020-09-30 | 12.75% |
| 2020-06-30 | 9.91% |
| 2020-03-31 | 8.18% |
| 2019-12-31 | 8.09% |
| 2019-09-30 | 8.66% |
| 2019-06-30 | 9.33% |
| 2019-03-31 | 9.41% |
| 2018-12-31 | 9.24% |
| 2018-09-30 | 3.29% |
| 2018-06-30 | 4.15% |
| 2018-03-31 | 2.49% |
| 2017-12-31 | 3.04% |
| 2017-09-30 | 8.83% |
| 2017-06-30 | 7.57% |
| 2017-03-31 | 10.18% |
| 2016-12-31 | 10.85% |
| 2016-09-30 | 11.10% |
| 2016-06-30 | 11.23% |
| 2016-03-31 | 10.71% |
| 2015-12-31 | 10.07% |
| 2015-09-30 | 8.52% |
| 2015-06-30 | 7.66% |
| 2015-03-31 | 7.96% |
| 2014-12-31 | 7.73% |
| 2014-09-30 | 9.40% |
| 2014-06-30 | 9.33% |
| 2014-03-31 | 8.34% |
| 2013-12-31 | 8.38% |
| 2013-09-30 | 4.38% |
| 2013-06-30 | 3.95% |
| 2013-03-31 | 4.32% |
| 2012-12-31 | 3.59% |
| 2012-09-30 | 0.33% |
| 2012-06-30 | 0.19% |
| 2012-03-31 | -0.02% |
| 2011-12-31 | 0.11% |
| 2011-09-30 | 6.37% |
| 2011-06-30 | 6.33% |
| 2011-03-31 | 7.95% |
| 2010-12-31 | 7.85% |
| 2010-09-30 | 8.70% |
| 2010-06-30 | 8.25% |
| 2010-03-31 | 6.09% |
| 2009-12-31 | 5.53% |
| 2009-09-30 | 5.05% |
| 2009-06-30 | 7.57% |
| 2009-03-31 | 8.55% |
| 2008-12-31 | 8.57% |
| 2008-09-30 | 9.56% |
| 2008-06-30 | 8.17% |
| 2008-03-31 | 8.48% |
| 2007-12-31 | 8.36% |
| 2007-09-30 | 7.87% |
| 2007-06-30 | 8.01% |
| 2007-03-31 | 7.18% |
| 2006-12-31 | 7.58% |
| 2006-09-30 | 4.67% |
| 2006-06-30 | 4.67% |
| 2006-03-31 | 5.02% |
| 2005-12-31 | 4.56% |
| 2005-09-30 | 7.97% |
| 2005-06-30 | 7.59% |
| 2005-03-31 | 7.02% |
| 2004-12-31 | 6.58% |
| 2004-09-30 | 6.19% |
| 2004-06-30 | 5.58% |
| 2004-03-31 | 4.71% |
| 2003-12-31 | 4.00% |
| 2003-09-30 | 2.05% |
| 2003-06-30 | 1.71% |
